Expanding CRISPR-Edited Cells
Expand CRISPR-edited cells to generate sufficient, high-quality cell populations for downstream characterization, functional validation and gene therapy process development. While expanding cultures, track cell counts and viability using a Beckman Coulter Life Sciences Vi-CELL BLU Cell Viability Analyzer. Characterize cellular metabolism and culture performance using mass spectrometry, including differential mass analysis using a SCIEX Triple Quad 7500 System. Automate and integrate analysis of metabolomics and cell-based measurements, as well as track all cell line batches, using the Genedata Biopharma Platform to enable data traceability, comparability and scalable workflow management.
Expansion Products
Vi-CELL BLU Cell Viability Analyzer
Fully automated trypan blue dye exclusion method High throughput 24 position carousel Supports 96 well plate Faster analysis time compared to Vi-CELL XR Single sign-on with Active Directory Facilitates 21 CFR Part 11
View ProductsGenedata Biopharma Platform: Biopharma Automation & AI
Genedata transforms biopharma R&D through automation, advanced analytics, and AI. As the first biologics-native technology company, we lead digitalization and enable data-driven decision-making for biopharma organizations worldwide. The Genedata Biopharma Platform combines a unified data model with workflow automation and embedded AI to accelerate and optimize end-to-end discovery and development of biologics and other modalities.
View Products
SCIEX 7500+ system
Have the confidence to tackle even the most challenging studies and run continuously at the highest level of performance. The SCIEX 7500+ system is a triple quadrupole engineered to maintain our highest sensitivity for up to twice as long in complex matrices. When you are under pressure to make critical decisions, you need a system innovated to rise to the challenge. Whether you're progressing high potency drug candidates into clinical trials, staying prepared for changing PFAS regulations, or investing years in researching a biomarker that could later be used by someone to help develop a diagnostic cancer test in a diagnostic application, the decisions you make count.
View Products
